Skip to main content
Top
Published in: BMC Anesthesiology 1/2023

Open Access 01-12-2023 | Heparin | Case Report

Heparin-resistance in AL amyloidosis: a case report

Authors: Elisabeth S. van Ede, Marlijn P. A. Hoeks, Jan Hofland, Vera D. Linssen, Toin H. van Kuppevelt, Elly M. Versteeg, Theo G. Hafmans, Arjan Diepstra, Benno Kusters, Sanne M. M. Vermorgen

Published in: BMC Anesthesiology | Issue 1/2023

Login to get access

Abstract

Background

Non-AT-III mediated heparin-resistance during CPB occurs by complex-forming with heparin-binding proteins. Currently, there are no specific recommendations for non-AT-III mediated heparin-resistance.

Case presentation

We present a fatal case of a 70-yr-old male-patient undergoing cardiac-surgery in which refractory heparin-resistance was observed. The massive AL amyloidosis found at autopsy is thought to be responsible and illustrates that awareness and knowledge of the etiology and perioperative strategies of non-AT-III mediated heparin-resistance is important.

Conclusion

For anticoagulation during cardiopulmonary bypass surgery in case of a non-AT-III medicated heparin resistance, we refer to the decision tree added to this manuscript and if necessary to consider direct thrombin inhibitors, such as bivalirudin or argatroban, as it bypasses the complexing pathway.
Appendix
Available only for authorised users
Literature
1.
go back to reference Finley A, Greenberg C. Review article: heparin sensitivity and resistance: management during cardiopulmonary bypass. Anesth Analg. 2013;116(6):1210–22.CrossRefPubMed Finley A, Greenberg C. Review article: heparin sensitivity and resistance: management during cardiopulmonary bypass. Anesth Analg. 2013;116(6):1210–22.CrossRefPubMed
2.
go back to reference Boneu B, Caranobe C, Sie P. Pharmacokinetics of heparin and low molecular weight heparin. Baillieres Clin Hematol. 1990;3(3):531–44.CrossRef Boneu B, Caranobe C, Sie P. Pharmacokinetics of heparin and low molecular weight heparin. Baillieres Clin Hematol. 1990;3(3):531–44.CrossRef
4.
go back to reference Christiansen J, Lindqvist B. Heparin-resistance in amyloidosis. Acta Med Scand. 1967;181(6):723–4.CrossRefPubMed Christiansen J, Lindqvist B. Heparin-resistance in amyloidosis. Acta Med Scand. 1967;181(6):723–4.CrossRefPubMed
5.
go back to reference Meneghetti MCZ, Hughes AJ, Rudd TR, et al. Heparan sulfate and heparin interactions with proteins. J R Soc Interface. 2015;12(110):0589.CrossRefPubMed Meneghetti MCZ, Hughes AJ, Rudd TR, et al. Heparan sulfate and heparin interactions with proteins. J R Soc Interface. 2015;12(110):0589.CrossRefPubMed
6.
go back to reference Li J-P, Kusche-Gullberg M. Heparan Sulfate: Biosynthesis, Structure, and Function. Int Rev Cell Mol Biol. 2016;325:215–73.CrossRefPubMed Li J-P, Kusche-Gullberg M. Heparan Sulfate: Biosynthesis, Structure, and Function. Int Rev Cell Mol Biol. 2016;325:215–73.CrossRefPubMed
7.
go back to reference Moss J, Shore I, Woodrow D. AA glomerular amyloid. An ultrastructural immunogold study of the colocalization of heparan sulphate proteoglycan and P component with amyloid fibrils together with changes in distribution of type IV collagen and fibronectin. Histopathology. 1994;24(5):427–35.CrossRefPubMed Moss J, Shore I, Woodrow D. AA glomerular amyloid. An ultrastructural immunogold study of the colocalization of heparan sulphate proteoglycan and P component with amyloid fibrils together with changes in distribution of type IV collagen and fibronectin. Histopathology. 1994;24(5):427–35.CrossRefPubMed
8.
go back to reference Snow AD, Bramson R, Mar H, Wight TN, Kisilevsky R. A temporal and ultrastructural relationship between heparan sulfate proteoglycans and AA amyloid in experimental amyloidosis. J Histochem Cytochem. 1991;39(10):1321–30.CrossRefPubMed Snow AD, Bramson R, Mar H, Wight TN, Kisilevsky R. A temporal and ultrastructural relationship between heparan sulfate proteoglycans and AA amyloid in experimental amyloidosis. J Histochem Cytochem. 1991;39(10):1321–30.CrossRefPubMed
9.
go back to reference Stenstad T, Magnus JH, Kolset SO, Cornwell GG 3rd, Husby G. Macromolecular properties of glycosaminoglycans in primary AL amyloid fibril extracts of lymphoid tissue origin. Scand J Immunol. 1991;34(5):611–7.CrossRefPubMed Stenstad T, Magnus JH, Kolset SO, Cornwell GG 3rd, Husby G. Macromolecular properties of glycosaminoglycans in primary AL amyloid fibril extracts of lymphoid tissue origin. Scand J Immunol. 1991;34(5):611–7.CrossRefPubMed
10.
go back to reference Sucker C, Hetzel GR, Grabensee B, Stockschlaeder M, Scharf RE. Amyloidosis and bleeding: pathophysiology, diagnosis, and therapy. Am J Kidney Dis. 2006;47(6):947–55.CrossRefPubMed Sucker C, Hetzel GR, Grabensee B, Stockschlaeder M, Scharf RE. Amyloidosis and bleeding: pathophysiology, diagnosis, and therapy. Am J Kidney Dis. 2006;47(6):947–55.CrossRefPubMed
11.
go back to reference Shore-Lesserson L, Baker RA, Ferraris VA, et al. The Society of Thoracic Surgeons, The Society of Cardiovascular Anesthesiologists, and The American Society of ExtraCorporeal Technology: Clinical Practice Guidelines-Anticoagulation During Cardiopulmonary Bypass. Ann Thorac Surg. 2018;105(2):650–62.CrossRefPubMed Shore-Lesserson L, Baker RA, Ferraris VA, et al. The Society of Thoracic Surgeons, The Society of Cardiovascular Anesthesiologists, and The American Society of ExtraCorporeal Technology: Clinical Practice Guidelines-Anticoagulation During Cardiopulmonary Bypass. Ann Thorac Surg. 2018;105(2):650–62.CrossRefPubMed
12.
go back to reference McNair E, Marcoux JA, Bally C, Gamble J, Thomson D. Bivalirudin as an adjunctive anticoagulant to heparin in the treatment of heparin resistance during cardiopulmonary bypass-assisted cardiac surgery. Perfusion. 2016;31(3):189–99.CrossRefPubMed McNair E, Marcoux JA, Bally C, Gamble J, Thomson D. Bivalirudin as an adjunctive anticoagulant to heparin in the treatment of heparin resistance during cardiopulmonary bypass-assisted cardiac surgery. Perfusion. 2016;31(3):189–99.CrossRefPubMed
13.
go back to reference Rössig L, Genth-Zotz S, Rau M, Heyndrickx GR, Schneider T, Gulba DC, Desaga M, Buerke M, Harder S, Zeiher AM, ARG-E04 study group. Argatroban for elective percutaneous coronary intervention: the ARG-E04 multi-center study. Int J Cardiol. 2011;148(2):214–9.CrossRefPubMed Rössig L, Genth-Zotz S, Rau M, Heyndrickx GR, Schneider T, Gulba DC, Desaga M, Buerke M, Harder S, Zeiher AM, ARG-E04 study group. Argatroban for elective percutaneous coronary intervention: the ARG-E04 multi-center study. Int J Cardiol. 2011;148(2):214–9.CrossRefPubMed
14.
go back to reference Seelhammer TG, Bohman JK, Schulte PJ, Hanson AC, Aganga DO. Comparison of Bivalirudin Versus Heparin for Maintenance Systemic Anticoagulation During Adult and Pediatric Extracorporeal Membrane Oxygenation. Crit Care Med. 2021;49(9):1481–92.CrossRefPubMed Seelhammer TG, Bohman JK, Schulte PJ, Hanson AC, Aganga DO. Comparison of Bivalirudin Versus Heparin for Maintenance Systemic Anticoagulation During Adult and Pediatric Extracorporeal Membrane Oxygenation. Crit Care Med. 2021;49(9):1481–92.CrossRefPubMed
15.
go back to reference Koster A, Faraoni D, Levy JH. Argatroban and Bivalirudin for Perioperative Anticoagulation in Cardiac Surgery. Anesthesiology. 2018;128(2):390–400.CrossRefPubMed Koster A, Faraoni D, Levy JH. Argatroban and Bivalirudin for Perioperative Anticoagulation in Cardiac Surgery. Anesthesiology. 2018;128(2):390–400.CrossRefPubMed
16.
go back to reference Martin ME, Kloecker GH, Laber DA. Argatroban for anticoagulation during cardiac surgery. Eur J Haematol. 2007;78(2):161–6.PubMed Martin ME, Kloecker GH, Laber DA. Argatroban for anticoagulation during cardiac surgery. Eur J Haematol. 2007;78(2):161–6.PubMed
17.
go back to reference Smith AI, Stroud R, Damiani P, Vaynblat M. Use of Argatroban for anticoagulation during cardiopulmonary bypass in a patient with heparin allergy. Eur J Cardiothorac Surg. 2008;34(5):1113–4.CrossRefPubMed Smith AI, Stroud R, Damiani P, Vaynblat M. Use of Argatroban for anticoagulation during cardiopulmonary bypass in a patient with heparin allergy. Eur J Cardiothorac Surg. 2008;34(5):1113–4.CrossRefPubMed
Metadata
Title
Heparin-resistance in AL amyloidosis: a case report
Authors
Elisabeth S. van Ede
Marlijn P. A. Hoeks
Jan Hofland
Vera D. Linssen
Toin H. van Kuppevelt
Elly M. Versteeg
Theo G. Hafmans
Arjan Diepstra
Benno Kusters
Sanne M. M. Vermorgen
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Anesthesiology / Issue 1/2023
Electronic ISSN: 1471-2253
DOI
https://doi.org/10.1186/s12871-023-02147-4

Other articles of this Issue 1/2023

BMC Anesthesiology 1/2023 Go to the issue